Search Results - "Castaing, D"

Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma by Le Roy, B., Gelli, M., Pittau, G., Allard, M.‐A., Pereira, B., Serji, B., Vibert, E., Castaing, D., Adam, R., Cherqui, D., Sa Cunha, A.

“…Background Locoregional extension of intrahepatic cholangiocarcinoma (ICC) at the time of diagnosis results in a low resectability rate and poor prognosis. The…”
Get full text

Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases by Adam, R., Imai, K., Castro Benitez, C., Allard, M.-A., Vibert, E., Sa Cunha, A., Cherqui, D., Baba, H., Castaing, D.

“…Background Although associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has been increasingly adopted by many centres, the…”
Get full text

Repeat hepatectomy for recurrent colorectal metastases by Wicherts, D. A., de Haas, R. J., Salloum, C., Andreani, P., Pascal, G., Sotirov, D., Adam, R., Castaing, D., Azoulay, D.

“…Background The oncological benefit of repeat hepatectomy for patients with recurrent colorectal metastases is not yet proven. This study assessed the value of…”
Get full text

Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison by Ruiz, A., van Hillegersberg, R., Siesling, S., Castro-Benitez, C., Sebagh, M., Wicherts, D.A., de Ligt, K.M., Goense, L., Giacchetti, S., Castaing, D., Morère, J., Adam, R.

“…Resection of breast cancer liver metastases (BCLM) combined with systemic treatment is increasingly accepted but not offered as therapeutic option. New…”
Get full text

Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance? by Viganò, L., MD PhD, Torzilli, G., MD PhD F.A.C.S, Cimino, M., MD, Imai, K., MD, Vibert, E., MD, Donadon, M., MD PhD, Castaing, D., MD, Adam, R., MD PhD

“…Abstract Background Two-stage hepatectomy (TSH) is the present standard for multiple bilobar colorectal liver metastases (CLM), but 25-35% of patients fail to…”
Get full text

Presidential address of Professor Denis Castaing by Castaing, D

Get full text

Long‐term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases by Imai, K., Allard, M.‐A., Castro Benitez, C., Vibert, E., Sa Cunha, A., Cherqui, D., Castaing, D., Baba, H., Adam, R.

“…Background Combining radiofrequency ablation (RFA) with hepatectomy may enable treatment with curative intent for patients with colorectal liver metastasis…”
Get full text

Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor by Vibert, E., Azoulay, D., Hoti, E., Iacopinelli, S., Samuel, D., Salloum, C., Lemoine, A., Bismuth, H., Castaing, D., Adam, R.

“…Liver transplantation (LT) for cirrhotic/Hepatocellular carcinoma (HCC) is associated with reduced survival in patients with poor histological features…”
Get full text

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV by Lévi, F.A., Boige, V., Hebbar, M., Smith, D., Lepère, C., Focan, C., Karaboué, A., Guimbaud, R., Carvalho, C., Tumolo, S., Innominato, P., Ajavon, Y., Truant, S., Castaing, D., De Baere, T., Kunstlinger, F., Bouchahda, M., Afshar, M., Rougier, P., Adam, R., Ducreux, M.

“…Systemic chemotherapy typically converts previously unresectable liver metastases (LM) from colorectal cancer to curative intent resection in ∼15% of patients…”
Get full text

Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry by Adam, R., Delvart, V., Karam, V., Ducerf, C., Navarro, F., Letoublon, C., Belghiti, J., Pezet, D., Castaing, D., Le Treut, Y. P., Gugenheim, J., Bachellier, P., Pirenne, J., Muiesan, P.

“…Between 2003 and 2012, 42 869 first liver transplantations performed in Europe with the use of either University of Wisconsin solution (UW; N = 24 562),…”
Get full text

Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases by de Haas, R. J., Adam, R., Wicherts, D. A., Azoulay, D., Bismuth, H., Vibert, E., Salloum, C., Perdigao, F., Benkabbou, A., Castaing, D.

“…Background: The optimal surgical strategy for patients with synchronous colorectal liver metastases (CLMs) is still unclear. The aim of this study was to…”
Get full text

Vascular reconstruction combined with liver resection for malignant tumours by Azoulay, D., Pascal, G., Salloum, C., Adam, R., Castaing, D., Tranecol, N.

“…Background The resectability criteria for malignant liver tumours have expanded during the past two decades. The use of vascular reconstruction after…”
Get full text

Short‐ and Long‐term Donor Morbidity in Right Lobe Living Donor Liver Transplantation: 91 Consecutive Cases in a European Center by Azoulay, D., Bhangui, P., Andreani, P., Salloum, C., Karam, V., Hoti, E., Pascal, G., Adam, R., Samuel, D., Ichai, Ph, Saliba, F., Castaing, D.

“…The lack of use of a common grading system in reporting morbidity impedes estimation of the true risk to a right lobe living donor (RLLD). We report outcomes…”
Get full text

Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension by Hosokawa, I., Adam, R., Allard, M.‐A., Pittau, G., Vibert, E., Cherqui, D., Sa Cunha, A., Bismuth, H., Miyazaki, M., Castaing, D.

“…Background Transjugular intrahepatic portasystemic stent shunt (TIPSS), instead of surgical shunt, has become the standard treatment for patients with…”
Get full text

Predictors of Long‐Term Survival After Liver Transplantation for Metastatic Endocrine Tumors: An 85‐Case French Multicentric Report by Le Treut, Y. P., Grégoire, E., Belghiti, J., Boillot, O., Soubrane, O., Mantion, G., Cherqui, D., Castaing, D., Ruszniewski, P., Wolf, P., Paye, F., Salame, E., Muscari, F., Pruvot, F. R., Baulieux, J.

“…Liver transplantation (LTx) for metastatic endocrine tumors (MET) remains controversial due to the lack of clear selection criteria. From 1989 to 2005, 85…”
Get full text

Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases by Adam, R., Avisar, E., Ariche, A., Giachetti, S., Azoulay, D., Castaing, D., Kunstlinger, F., Levi, F., Bismuth, F.

Get full text

Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases by Imai, K., Allard, M.-A., Castro Benitez, C., Vibert, E., Sa Cunha, A., Cherqui, D., Castaing, D., Bismuth, H., Baba, H., Adam, R.

“…Background Although recent advances in surgery and chemotherapy have increasingly enabled hepatectomy in patients with initially unresectable colorectal liver…”
Get full text

Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases by Wicherts, D. A., de Haas, R. J., Andreani, P., Sotirov, D., Salloum, C., Castaing, D., Adam, R., Azoulay, D.

“…Background: Portal vein embolization (PVE) increases the resectability of initially unresectable colorectal liver metastases (CLM). This study evaluated…”
Get full text

Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma by Doussot, A., Lim, C., Gómez Gavara, C., Fuks, D., Farges, O., Regimbeau, J. M., Azoulay, D.

“…Background The impact of morbidity on long‐term outcomes following liver resection for intrahepatic cholangiocarcinoma is currently unclear. Methods This was a…”
Get full text

Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus by MUTIMER, David J, GUNSON, Bridget, CHEN, John, BERENGUER, J, NEUHAUS, Peter, CASTAING, D, GARCIA-VALDECASAS, J. C, SALIZZONI, M, MORENO, Gonzalez E, MIRZA, Darius

“…Hepatitis C virus (HCV) infection has become the most common indication for liver transplantation (LT). Graft and patient survival are adversely affected by…”
Get full text